Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Science Immunology|April 11, 2025
Psychological stress increases skin infection through the action of TGFβ to suppress immune-acting fibroblastsHung Chan, Fengwu Li, Tatsuya Dokoshi, et al.
Orphanet Journal of Rare Diseases|February 16, 2021
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension studyWilliam R Lumry, Bruce Zuraw, Marco Cicardi, et al.
Pediatrics|December 8, 2020
Invasive Bacterial Infections in Afebrile Infants Diagnosed With Acute Otitis MediaSon H McLaren, Andrea T Cruz, Kenneth Yen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary AngioedemaWilliam R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2026
An Open-Label Phase 1b/2 Trial of Navenibart, a Long-Acting Plasma Kallikrein Inhibitor for Hereditary AngioedemaAleena Banerji, Timothy Craig, Karl Sitz, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Cellular and Molecular Neurobiology|June 5, 2026
Postmortem Evidence of Lymphatic Vessels Located at the Boundary of Central and Peripheral Nervous Systems in the Cervical SpineShalin S Bhatt, Caitlin R Coker, Lauren K Bagian, et al.
European Journal of Preventive Cardiology|September 13, 2024
Global burden of cardiovascular diseases: projections from 2025 to 2050Bryan Chong, Jayanth Jayabaskaran, Silingga Metta Jauhari, et al.
Lancet (London, England)|March 3, 2023
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trialTimothy J Craig, Avner Reshef, H Henry Li, et al.
Pageof 34